Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-25-000042

Options or other derivatives

  • See Remarks acquired 203,333 shares (grant or award)
  • See Remarks returned 203,333 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Alenson Carman See Remarks 2025-08-01 Returned to the company · Stock Option (right to buy) −16,083 0 D
Alenson Carman See Remarks 2025-08-01 Grant or award · Stock Option (right to buy) +16,083 16,083 D
Alenson Carman See Remarks 2025-08-01 Returned to the company · Stock Option (right to buy) −90,498 0 D
Alenson Carman See Remarks 2025-08-01 Grant or award · Stock Option (right to buy) +90,498 90,498 D
Alenson Carman See Remarks 2025-08-01 Returned to the company · Stock Option (right to buy) −6,254 0 D
Alenson Carman See Remarks 2025-08-01 Grant or award · Stock Option (right to buy) +6,254 6,254 D
Alenson Carman See Remarks 2025-08-01 Returned to the company · Stock Option (right to buy) −90,498 0 D
Alenson Carman See Remarks 2025-08-01 Grant or award · Stock Option (right to buy) +90,498 90,498 D
Loading xslF345X05/wk-form4_1754440946.xml…